Ambey Laboratories IPO will open for subscription from 04 July 2024. The company aims for an issue size of ₹44.68 Cr through this IPO.
Company Overview
| Full name | Ambey Laboratories Limited |
| Sector | Chemicals |
| Industry | Pesticides & Agrochemicals |
| Company Website | http://www.ambeylab.com/ |
About Company
Ambey Laboratories has been dedicated to the manufacturing of agrochemical products for crop protection for nearly four decades. The company specializes in producing and supplying “2, 4-D base chemicals,” adhering to the highest quality standards and complying with the stringent Environmental, Health, and Safety (EHS) regulations in the chemical industry.
The company’s manufacturing facility in Behror, Rajasthan, is certified with ISO 9001:2015 by the Quality Research Organization and ISO 14001:2015 by the United Accreditation Foundation. As of 31 January 2024, the company employs 195 people in various departments.
Currently, the company produces an array of chemicals: 2,4-D Acid 98% TC, 2,4-D Sodium 95% SP, 2,4-D Amine in concentrations of 866, 720, and 480g/l SL, 2,4-D Ethyl Hexyl Ester 96% TC, and 2,4-D Ethyl Ester 96% TC. Their product line also includes Chlorpyriphos available in 97% TC, 20% EC, and 50% EC formulations, Thiamethoxam in 96% TC, 25% WG, and 75% SG, Pretilachlor in 95% TC, 50% EC, and 37% EW, Metribuzin at 97% TC and 70% WS, Hexaconazole in 92% TC, 5% SC, 5% EC, and 10% EC, and Metalaxyl at 98% TC and 35% WS. These products serve a diverse clientele, including major corporations such as Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd.
The Objectives of the Issue
- To meet Working Capital Requirements
- General corporate purposes
- Issue related expenses
Ambey Laboratories IPO Timetable
| IPO Opening date | 04 July 2024 |
| IPO Closing | 08 July 2024 |
| Basis of Allotment | 09 July 2024 |
| Initiation Refund | 10 July 2024 |
| Credit to Demat Account | 10 July 2024 |
| Listing Date | 11 July 2024 |
Ambey Laboratories IPO details
| Issue type | Book Built Issue IPO |
| IPO issue size | ₹44.68 Cr – 6,570,000 shares |
| Fresh Issue | ₹42.55 Cr – 6,258,000 shares |
| Offer for sale | ₹2.12 Cr – 312,000 shares |
| Face value | ₹10 per share |
| Price Band | ₹65 to ₹68 per share |
| Lot size | 2000 Shares |
| Market Maker portion | 312,000 shares |
| Shareholding pre-issue | 18,688,819 |
| Shareholding post-issue | 25,258,819 |
| Listing Exchange | NSE SME |
Ambey Laboratories IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹136,000 |
| Retail (Max) | 1 | 2000 | ₹136,000 |
| HNI (Min) | 2 | 4,000 | ₹272,000 |
Ambey Laboratories Offer Documents
Ambey Laboratories IPO Reservation Details
| QIB Shares Offered | 50% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 35% |
Ambey Laboratories Financial Performance
| FY 2021 | FY 2022 | FY 2023 | 10M FY 2024 | |
| Revenue | 81.74 | 84.60 | 104.82 | 100.32 |
| Expenses | 72.01 | 74.26 | 96.41 | 87.64 |
| Net income | 10.34 | 3.57 | 4.57 | 6.08 |
Ambey Laboratories Valuations & Margins
| FY 2021 | FY 2022 | FY 2023 | |
| EPS | 21.12 | 7.08 | 2.57 |
| PE ratio | – | – | 25.29 – 26.46 |
| RONW (%) | (80.84) | 63.82 | 21.40 |
| NAV | (16.07) | 37.78 | 13.32 |
| ROCE (%) | 58.51 | 12.53 | 12.75 |
| EBITDA (%) | 12.73 | 12.83 | 10.52 |
| Debt/Equity | (4.19) | 0.95 | 0.58 |
Company Promoters
- Archit Gupta
- Arpit Gupta
- Sarina Gupta
- Rishita Gupta.
Promoter Holding
| Pre Issue Share Holding | 94.97% |
| Post Issue Share Holding |
Ambey Laboratories GMP Update
| Date | Consolidated IPO GMP | Kostak | Subject to Sauda |
| Coming soon | – | – | – |
Ambey Laboratories IPO Subscription Update
Coming Soon
Ambey Laboratories IPO Allotment Status
Ambey Laboratories IPO allotment status will be available on Link Intime’s website. Click on Link Intime IPO weblink to get allotment status.
Ambey Laboratories IPO Listing Details
| Listing Date | |
| BSE Scrip Code | |
| NSE Symbol | |
| ISIN | |
| Final Issue Price |
Ambey Laboratories Listing Day Update
| Listing Exchange | |
| Final Issue Price | |
| Open | |
| Low | |
| High | |
| Last Trade |
Ambey Laboratories Lead Manager(s)
FAST TRACK FINSEC PRIVATE LIMITED
Office No. V-116, 1st Floor, New Delhi House, 27,
Barakhamba Road, New Delhi – 110001
Phone: +91 11 43029809
Email: vikasverma@ftfinsec.com / investor@ftfinsec.com
Website: www.ftfinsec.com
Ambey Laboratories Registrar
LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park L.B.S. Marg,
Vikhroli West, Mumbai – 400 083, Maharashtra
Telephone: +91 810 811 4949
Email: ambeylab.ipo@Linkintime.co.in
Website: www.linkintime.co.in
Ambey Laboratories Contact Details
AMBEY LABORATORIES LIMITED
Ground Floor, Property No.555 Tarla Mohalla,
Ghitorni, South West Delhi, New Delhi -110030
Phone: 0124-4000788
E-mail: cs@ambeylab.com
Website: ambeylab.com
Ambey Laboratories IPO FAQs
What is the Ambey Laboratories’ offer size?
Ambey Laboratories’ offer size is ₹ 42.71 – 44.68 crores.
What is the Ambey Laboratories offer price band?
Ambey Laboratories public offer price is ₹ 65 – 68 per share.
What is the lot size of the Ambey Laboratories IPO?
Ambey Laboratories offer a lot size is 2,000 shares.
What is Ambey Laboratories Offer GMP today?
Ambey Laboratories IPO GMP today is ₹ NA per share.
What is the Ambey Laboratories kostak rate today?
Ambey Laboratories kostak rate today is ₹ NA per application.
What is Ambey Laboratories Subject to the Sauda rate today?
Ambey Laboratories is Subject to the Sauda rate today is ₹ NA per application.
Final thoughts
Ambey Laboratories IPO is going to hit Dalal Street soon. applying for an IPO is purely a personal choice. Study the company well and subscribe if you feel good about it. I hope this post will give you enough details to research the company fundamentally. learn well and make wise decisions.
Happy Investing
